retinal cell ganglion neuroprotectants Cogent

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameretinal cell ganglion neuroprotectants Cogent
Drug Alias NameCNIC-1030CNIC-762CNIC-705
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationRetinal DiseasesGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCogent Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCogent Neuroscience Inc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationRetinal DiseasesGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A